Researchers have uncovered a novel biological pathway that can lead to seizures when disrupted. The findings also provide a new approach to improve the diagnosis of epilepsy, for which a genetic cause cannot be found in about 50 % of individuals with the condition
Achieving and sustaining a blood ketone level of 0.5 mmol/L is crucial for weight loss in ketogenic diets, offering a new approach to dietary monitoring.
A high-fat, low-carbohydrate diet, also called a ketogenic diet, can help some people lose weight by forcing their bodies to burn fat for fuel instead of sugar.
Karina Acton Reid recounts caring for her husband with young-onset Alzheimer’s disease presenting as posterior cortical atrophy while raising two young children. Her perspective shows how visual disorientation, diagnostic delays, changing family roles, and inadequate age-appropriate support affect the entire household.
EpilepsyGTx, a biotechnology company developing cutting-edge gene therapies to treat refractory epilepsy, and ClearPoint Neuro ("ClearPoint"), a global therapy-enabling company offering precise navigation and delivery to the brain, today announced a partnership to support the targeted delivery of EpilepsyGTx's lead gene therapy candidate, EPY201, for focal refractory epilepsy (FRE).
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of
our websites
and requested to be notified of additional information.
